Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/500 - 1/2000. Predicted molecular weight: 32 kDa.
1/20 - 1/200.
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.
Expressed by most tissues. Present in plasma.
Contains 1 IGFBP N-terminal domain.
Contains 1 thyroglobulin type-1 domain.
IGFBP3 levels are higher during extrauterine life and peak during puberty.
The thyroglobulin type-1 domain mediates interaction with HN.
Phosphorylation sites are present in the extracelllular medium.
Information by UniProt
Acid stable subunit of the 140 K IGF complex antibody
Binding protein 29 antibody
Binding protein 53 antibody
Anti-IGFBP3 antibody [MM0342-6U23] (ab89331) 使用論文
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"